Recombinant Tissue Factor as Substitute for Conventional Thromboplastin in the Prothrombin Time Test

Summary

Relipidated recombinant tissue factor (r-TF) has been assessed in comparison with conventional rabbit brain thromboplastin (Manchester Reagent) for its suitability for measurement of prothrombin time (PT). The International Sensitivity Index (ISI) of r-TF calibrated against the International Reference Preparation BCT/253 (human plain) was found to be 0.96 and 1.12 with instrumental and manual techniques. Our study of plasmas from patients with congenital deficiencies of clotting factors covering a wide range of severity demonstrates that r-TF is able to detect even minor deficiencies of factors involved in the extrinsic and common coagulation pathways. Patients with liver diseases were correctly diagnosed with a prevalence of abnormal results comparable for both reagents. Between-assay reproducibility expressed as coefficient of variation was 2.3 % and 3.9 % at normal and abnormal PT levels.

In conclusion, our evaluation shows that relipidated r-TF possesses the necessary requisites of sensitivity, diagnostic accuracy and reproducibility which make it a suitable candidate for PT determination both for monitoring oral anticoagulant therapy and diagnosing congenital and acquired clotting factor deficiencies. Moreover, being a highly defined reagent it may constitute a step forward in the standardization of PT testing.

• References

• 1 Quick A. The prothrombin in hemophilia and obstructive jaundice. J Biol Chem 1935; 109: 73-74
• 2 Ingram GIC, Brozovic M. Slater NGR Bleeding Disorders, Investigation and Management. Blackwell Scientific Publications; Oxford: 1982. pp 277-328
• 3 Rehemtulla A, Pepe M, Edgington TS. High level expression of recombinant human tissue factor in Chinese hamster ovary cells as a human thromboplastin. Thromb Haemostas 1991; 65: 521-527
• 4 Chantarangkul V, Tripodi A, Mannucci PM. Evaluation of a fully automated centrifugal analyzer for performing coagulation tests. Clin Chem 1987; 33: 1888-1890
• 5 World Health Organization. Recommended methodology for using WHO International reference preparations for thromboplastins. Available from World Health Organization 1211 Geneva 27, Switzerland.
• 6 Poggio M, van den Besselaar AMHP, van der Velde EA, Bertina RM. The effect of some instruments for prothrombin time testing on the International Sensitivity Index (ISI) of two rabbit tissue thromboplastin reagents. Thromb Haemostas 1989; 62: 868-874
• 7 Thomson JM, Tomenson JA, Poller L. The calibration of the second primary international reference preparation for thromboplastin (thromboplastin, human, plain, coded BCT/253). Thromb Haemostas 1984; 52: 336-342
• 8 Kirkwood TBL. Calibration of reference thromboplastins and standardization of the prothrombin time ratio. Thromb Haemostas 1983; 49: 238-244
• 9 Korsan-Bengsten K. Comparison between various methods used to control dicumarol therapy. Acta Med Scand 1970; 188: 327-335
• 10 Poller L, Thomson JM. National survey of value of plasma standards for anticoagulant therapy. Br Med J 1968; 2: 88-90
• 11 Poller L, Thomson JM. The Manchester Comparative Reagent. Human Blood Coagulation, Boerhaave Series, Leiden University Press; Leiden, The Netherlands: 1969. pp 290-294
• 12 Zucker S, Cathey MH, Sox PJ, Hall EC. Standardization of laboratory tests for controlling anticoagulant therapy. Am J Clin Pathol 1970; 53: 348-354
• 13 Poller L. The effect of the use of different tissue extracts on one-stage prothrombin time. Acta Haematol 1964; 32: 292-298
• 14 Loeliger EA, van den Besselaar AMHP, Lewis SM. Reliability and clinical impact of the normalization of the prothrombin times in oral anticoagulant control. Thromb Haemostas 1985; 53: 148-154
• 15 Palareti G, Coccheri S, Poggi M, Bonetti M, Cervi V, Mazzucca A, Savoia M, Veri L, Fiori F, Gaspari G, Palareti A. Oral anticoagulant therapy control: evidence that INR expression improves the interlaboratory comparability of results. The Bologna oral anticoagulant control exercise. Thromb Haemostas 1987; 58: 905-910
• 16 WHO Expert Committee on Biological Standardization Thirty-third report. Technical Report Series 687 WHO; Geneva: 1983
• 17 Taberner DA, Poller L, Thomson JM, Darby KV. Effect of International Sensitivity Index (ISI) of thromboplastins on precision of International Normalized Ratios (INR). J Clin Pathol 1989; 42: 92-96